Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03530774 · ClinicalTrials.gov registry record · NA
Supplemental Egg Protein Intervention in Older Adults
A NA study, sponsored by The University of Texas at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT03530774: Completed NA study, sponsored by The University of Texas at San Antonio.
NCT03530774 is a NA study that has completed, run by The University of Texas at San Antonio. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03530774, a NA study, has completed, sponsored by The University of Texas at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
Older adults are at risk for developing sarcopenia, or age-related muscle loss, which increased the risk of disabilities, falls, and loss of independence. Many older adults do not consume enough protein each day to maintain their muscle mass and this study aims to investigate if consumption daily egg white protein supplement can help maintain muscle mass and functionality in community-dwelling older adults. Food insecure older adults that attend congregate nutrition sites will be targeted.
Primary Outcome
Dual-energy X-ray absorptimetry
Interventions
- DIETARY_SUPPLEMENT powdered egg white protein supplement
- DIETARY_SUPPLEMENT maltodextrin supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-05-31 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
What the finished NCT03530774 record still lists
NCT03530774 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which powdered egg white protein supplement is the first listed.
NCT03530774 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03530774 about?
NCT03530774 is a clinical study titled "Supplemental Egg Protein Intervention in Older Adults". Older adults are at risk for developing sarcopenia, or age-related muscle loss, which increased the risk of disabilities, falls, and loss of independence. Many older adults do not consume enough protein each day to maintain their muscle mass and this study aims to investigate if consumption daily eg...
What is the current status of trial NCT03530774?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2017-05-31. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT03530774?
The interventions under investigation include: powdered egg white protein supplement (DIETARY_SUPPLEMENT), maltodextrin supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03530774?
This trial is sponsored by The University of Texas at San Antonio, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03530774's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI